Response to Salvage Therapy, The Main Prognosis Factor in Patients with Refractory or Relapsed Diffuse Large B-Cell Lymphoma Treated with R-ESHAP and Autologous Stem Cell Transplantation

被引：0
|
作者：
Salido Toimil, F. [1 ]
Torres Carrete, P. [1 ]
Deben Ariznavarreta, G. [1 ]
Varela Gomez, M. R. [1 ]
Lopez Fernandez, M. F. [1 ]
Noriega Concepcion, V. [1 ]
机构：
[1] Complexo Hosp Univ A Coruna, La Coruna, Spain
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P352
引用
收藏
页码：S300 / S301
页数：2
相关论文
共 50 条
  • [41] Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Friedberg, Jonathan W.
    HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM, 2011, : 498 - 505
  • [42] Prognostic value of FDG-PET prior to autologous stem cell transplantation for relapsed and refractory diffuse large B-cell lymphoma
    Sauter, Craig S.
    Matasar, Matthew J.
    Meikle, Jessica
    Schoder, Heiko
    Ulaner, Gary A.
    Migliacci, Jocelyn C.
    Hilden, Patrick
    Devlin, Sean M.
    Zelenetz, Andrew D.
    Moskowitz, Craig H.
    BLOOD, 2015, 125 (16) : 2579 - 2581
  • [43] The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma
    Gi-June Min
    Young-Woo Jeon
    Tong Yoon Kim
    Daehun Kwag
    Byung-Su Kim
    Joonyeop Lee
    Jong Hyuk Lee
    Sung-Soo Park
    Silvia Park
    Jae-Ho Yoon
    Sung-Eun Lee
    Byung-Sik Cho
    Ki-Seong Eom
    Yoo-Jin Kim
    Seok Lee
    Hee-Je Kim
    Chang-Ki Min
    Jong Wook Lee
    Seok-Goo Cho
    Scientific Reports, 13
  • [44] The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma
    Min, Gi-June
    Jeon, Young-Woo
    Kim, Tong Yoon
    Kwag, Daehun
    Kim, Byung-Su
    Lee, Joonyeop
    Lee, Jong Hyuk
    Park, Sung-Soo
    Park, Silvia
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Lee, Seok
    Kim, Hee-Je
    Min, Chang-Ki
    Lee, Jong Wook
    Cho, Seok-Goo
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [45] Outcomes of Patients with Refractory/Relapsed Diffuse Large B-Cell Lymphoma Who Progress After Autologous Stem Cell Transplantation in the Rituximab Era.
    Nagle, Sarah J.
    Woo, Kaitlin
    Mick, Rosemarie
    Schuster, Stephen J.
    Nasta, Sunita D.
    Stadtmauer, Edward A.
    Svoboda, Jakub
    BLOOD, 2012, 120 (21)
  • [46] Effect of rituximab (R) on clinical outcomes after autologous stem cell transplantation (ASCT) in pts with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
    Adegbola, O.
    Andreadis, C.
    Schuster, S. J.
    Chong, E. A.
    Nasta, S. D.
    Porter, D. L.
    Luger, S. M.
    Tsai, D. E.
    Cunningham, K.
    Stadtmauer, E. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [47] Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma
    Yuan, Xianggui
    Li, Xian
    Huang, Yurong
    Jin, Xueli
    Liu, Hui
    Zhao, Aiqi
    Zhang, Weiping
    Qian, Wenbin
    Liang, Yun
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [48] Clinical Relevance of MYC/BCL2 and Cell of Origin in Patients with Relapsed Diffuse Large B-Cell Lymphoma Treated with Autologous Stem Cell Transplantation
    Wang, Yingjun
    Young, Ken H.
    Milton, Denai R.
    Ledesma, Celina
    Jabbour, Elias
    Xu-Monette, Zijun Yidan
    Molldrem, Jeffrey J.
    Anderlini, Paolo
    Alousi, Amin M.
    Bashir, Qaiser
    Daher, May
    Fayad, Luis E.
    Iyer, Swaminathan P.
    Kebriaei, Partow
    Marin, David
    Mehta, Rohtesh S.
    Olson, Amanda L.
    Popat, Uday
    Samaniego, Felipe
    Westin, Jason R.
    Qazilbash, Muzaffar H.
    Im, Jin S.
    Rondon, Gabriela
    Gulbis, Alison
    Champlin, Richard E.
    Khouri, Issa F.
    BLOOD, 2019, 134
  • [49] Acalabrutinib Plus RICE Followed By Autologous Hematopoietic Cell Transplantation and/or Acalabrutinib Maintenance Therapy for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Bailey, Neil
    Tsomo, Tenzin
    Szeto, Jennie
    Bensinger, William I.
    Egan, Daniel
    Hegerova, Livia
    Mawad, Raya
    Batchelder, Ami
    Fesler, Joanna
    Holdread, Heather
    Glennie, Sonia
    Hall, Judson
    Ferry, Joey
    Bailey, Megumi
    Kane, David
    Pagel, John M.
    Patel, Krish
    BLOOD, 2020, 136
  • [50] Real World Outcomes of Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma Who Are Ineligible for Autologous Stem Cell Transplantation and Receive Commercially-Available Salvage Therapy
    Ayers, Emily C.
    Margolis, David J.
    Gimotty, Phyllis A.
    Landsburg, Daniel J.
    BLOOD, 2019, 134
12345